PCI Pharma Services:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PCI Pharma Services - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10785
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PCI Pharma Services (PCI) is a pharmaceutical service provider that offers clinical, manufacturing and packaging solutions. The company offers clinical services such as clinical supplies management, clinical planning and support, project management, IVRS-IWRS, support services and data access, among others. It’s commercial packaging includes product launch services, packaging development and design, qp services, supported delivery forms, customer and product types, and serialization and anti-counterfeiting among others. PCI’s support services include Dedicated Project Management, Protocol Interpretation, Language Translation and Distribution and Logistics Planning among others. The company operates in the US, the UK and Japan. PCI is headquartered in Philadelphia, Pennsylvania, the US.

PCI Pharma Services – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PCI Pharma Services, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PCI Pharma Services, Medical Devices Deals, 2012 to YTD 2018 9
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PCI Pharma Services, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Partners Group to Acquire PCI Pharma Services from Frazier Healthcare Ventures 11
Acquisition 13
PCI Pharma Services Acquires Sherpa Clinical Packaging 13
PCI Pharma Services Acquires Pharmaceutical Packaging Professionals 14
PCI Pharma Acquires Millmount Healthcare 15
Packaging Coordinators Acquires Biotec Services 16
Packaging Coordinators Completes Acquisition of Penn Pharma 17
PCI Pharma Services – Key Competitors 18
PCI Pharma Services – Key Employees 19
PCI Pharma Services – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Strategy And Business Planning 22
Oct 15, 2018: PCI Clinical Services announces new facility dedicated to clinical trial 22
Aug 29, 2018: PCI announces expansion of its industry-leading cold chain infrastructure with dedicated -40°C facility 24
Apr 25, 2018: PCI Pharma Services Announces New High Containment Packaging Facility at Ireland Site 26
Mar 21, 2018: Expansion of Analytical Laboratories at Tredegar Center of Excellence for Contained Manufacturing 27
Mar 19, 2018: PCI’s Tredegar Site Announces Significant Expansion of Analytical Laboratories at its Center of Excellence for Contained Manufacturing 28
Corporate Communications 29
Jul 12, 2018: PCI Pharma Services Names Salim Haffar As Chief Executive Officer 29
Jul 12, 2018: Salim Haffar to join PCI Pharma Services as Chief Executive Office 31
May 03, 2018: PCI Welcomes Melissa Ertl as Quality Head for Philadelphia 32
Apr 20, 2018: Mitch Lewandowski Joins PCI Pharma Services as Executive Director of Quality 33
Feb 25, 2018: PCI Welcomes Brad Payne as Senior Vice President of Operations 34
Other Significant Developments 35
Nov 14, 2018: Rockford site expansion to support growth and flexibility 35
Feb 22, 2018: PCI Welcomes UK Government to US Center of Excellence and Headquarters 36
Feb 03, 2018: PCI to Showcase Serialization Expertise at Pharmapack 2018 37
Nov 01, 2017: PCI Announces Further Investment in Fully Contained Xcelodose 600S Technology Delivering Excellence in Clinical Services 38
Oct 19, 2017: Molecule to Market: PCI Affirms Position as Market-Leading Pharmaceutical Outsourcing Provider 39
Aug 07, 2017: PCI Pharma Services: FastTrack Service Launch 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
PCI Pharma Services, Pharmaceuticals & Healthcare, Key Facts 2
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PCI Pharma Services, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PCI Pharma Services, Deals By Therapy Area, 2012 to YTD 2018 8
PCI Pharma Services, Medical Devices Deals, 2012 to YTD 2018 9
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Partners Group to Acquire PCI Pharma Services from Frazier Healthcare Ventures 11
PCI Pharma Services Acquires Sherpa Clinical Packaging 13
PCI Pharma Services Acquires Pharmaceutical Packaging Professionals 14
PCI Pharma Acquires Millmount Healthcare 15
Packaging Coordinators Acquires Biotec Services 16
Packaging Coordinators Completes Acquisition of Penn Pharma 17
PCI Pharma Services, Key Competitors 18
PCI Pharma Services, Key Employees 19
PCI Pharma Services, Other Locations 20
PCI Pharma Services, Subsidiaries 20

List of Figures
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PCI Pharma Services, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[PCI Pharma Services:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nihon Kohden Corp (6849):医療機器:M&Aディール及び事業提携情報
    Summary Nihon Kohden Corp (Nihon Kohden) is a provider of medical electronic equipment to support treatment in clinical areas of emergency response; testing, diagnosis, treatment, and rehabilitation. Its major products include patient monitors, electroencephalographs, evoked potential and electromyo …
  • BlastGard International, Inc.:企業の戦略・SWOT・財務分析
    SummaryBlastGard International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Alternative Energy Partners, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Alternative Energy Partners, In …
  • Spectral Medical Inc (EDT):企業の財務・戦略的SWOT分析
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …
  • The Hiroshima Bank, Ltd.:企業の戦略・SWOT・財務分析
    SummaryThe Hiroshima Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Pro-Dex, Inc. (PDEX):企業の財務及び戦略的SWOT分析
    Summary Pro-Dex, Inc. (Pro-Dex) is a medical device company that designs, develops, manufactures and markets powered surgical devices, multi-axis motion controls, and custom motors for harsh environments. The company offers products such as powered surgical drivers, motion controllers, motors, drive …
  • Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Fortitech Inc.:企業の戦略・SWOT・財務分析
    SummaryFortitech Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Neurocrine Biosciences Inc (NBIX)-製薬・医療分野:企業M&A・提携分析
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • University of Strathclyde(製薬・医療分野):企業M&A動向
    Summary University of Strathclyde (Strathclyde) is an educational research university. It focuses on providing students with quality education, innovative teaching, learning technologies and facilities. The university has strong reputation for its teaching and research along with its strong linkages …
  • Imaging Dynamics Company, Ltd. (IDL):(医療機器分野)企業M&A及び提携動向
    Summary Imaging Dynamics Company, Ltd. (IDC) is a medical technology company. The company provides solutions in medical imaging and digital radiography technology. Its products include 2200 X-series, 1600 plus X-series, 1600 X-series, 1590 X-series, imaging processing software, X-ray dose monitor an …
  • Lophius Biosciences GmbH:企業のM&A・提携動向(医療機器分野)
    Summary Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets innovative T cell-based diagnostic systems and research tools in the areas of infectious and autoimmune diseases, and transplantation. The company offers diagnostic kits, such as T-Track ImmunoScan assay …
  • New Silkroad Culturaltainment Limited.:戦略・SWOT・企業財務分析
    New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report Summary New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • MITIE Group plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Grupa Zywiec S.A.:企業の戦略・SWOT・財務分析
    Grupa Zywiec S.A. - Strategy, SWOT and Corporate Finance Report Summary Grupa Zywiec S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vivimed Labs Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Vivimed Labs Limited Mergers an …
  • EOG Resources, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EOG Resources, Inc. Mergers and …
  • Mesoblast Ltd (MSB):製薬・医療:M&Aディール及び事業提携情報
    Summary Mesoblast Ltd (Mesoblast) is a regenerative medicine company, which develops regenerative cell-based products. Its pipeline product candidates include MPC-150-IM, which is under development for the treatment of chronic congestive heart failure; MSC-100-IV, for the treatment of acute graft ve …
  • Idogen AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Idogen AB (Idogen) is a biotechnology company that develops tolerogenic vaccines which reprogram the immune system of paitents. The company provides product portfolio such as antibodies for autoimmune diseases, organ rejection after transplantation and several other disease conditions. It de …
  • 3D Systems Corporation:企業のM&A・事業提携・投資動向
    3D Systems Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3D Systems Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆